Kala Pharmaceuticals Inc. (KALA)
6.06
-0.26 (-4.11%)
At close: Mar 28, 2025, 3:59 PM
6.27
3.54%
Pre-market: Mar 31, 2025, 04:11 AM EDT
Kala Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -42.2M | -44.82M | -142.6M | -104.33M | -94.35M | -66.74M | -42.21M | -33.17M | -16.68M | -19.36M | -10.65M |
| Depreciation & Amortization | 303K | 537K | 975K | 912K | 843K | 955K | 287K | 297K | 330K | 298K | 201K |
| Stock-Based Compensation | 7.46M | 7.01M | 16.09M | 13.31M | 9.99M | 8.62M | 3.57M | 2.07M | 638K | n/a | n/a |
| Other Working Capital | 3.18M | -14.28M | -1.83M | -2.24M | 6.67M | 160.02M | 2.1M | 2.02M | -36K | 1.83M | 156K |
| Other Non-Cash Items | -2.39M | -42.12M | 22.51M | 2.99M | 2.73M | 274K | 111K | 106K | 134K | 1.54M | -277K |
| Deferred Income Tax | n/a | n/a | 5.42M | -5K | n/a | 390K | 1.84M | 1.67M | 151K | n/a | n/a |
| Change in Working Capital | 8.89M | 491K | -10.62M | -3.57M | -11.94M | 2.38M | 2.3M | 1.68M | 340K | 2.17M | -113K |
| Operating Cash Flow | -27.93M | -78.91M | -108.23M | -90.69M | -92.72M | -54.12M | -34.1M | -27.35M | -15.09M | -15.36M | -10.84M |
| Capital Expenditures | -610K | -313K | -886K | -1.94M | -1.33M | -1.58M | -480K | -153K | -252K | -225K | -789K |
| Acquisitions | n/a | 62.91M | -4.65M | 2.07M | n/a | n/a | n/a | n/a | n/a | 3K | n/a |
| Purchase of Investments | -9.87M | -4.99M | n/a | -113.59M | n/a | n/a | n/a | n/a | n/a | n/a | -52K |
| Sales Maturities Of Investments | 10M | 5M | 76.25M | 37.33M | n/a | n/a | n/a | n/a | n/a | 40K | n/a |
| Other Investing Acitivies | 47K | 114K | 92K | -2.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -429K | 62.72M | 70.8M | -78.21M | -1.33M | -1.58M | -480K | -153K | -252K | -182K | -841K |
| Debt Repayment | -10M | -40.04M | -263K | -32K | -30K | 52.81M | 8.89M | n/a | 5M | 21.12M | 16.04M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -30K | 301K | 1.58M | 2.1M | 587K | 530K | 802K | 67.21M | 5.48M | n/a | n/a |
| Financial Cash Flow | 8.51M | -7.94M | 42.55M | 160.63M | 8.98M | 124.1M | 103.7M | 67.21M | 10.48M | 20.85M | 15.95M |
| Net Cash Flow | -19.85M | -24.13M | 5.12M | -8.28M | -85.07M | 68.41M | 69.12M | 39.71M | -4.86M | n/a | n/a |
| Free Cash Flow | -28.54M | -79.22M | -109.12M | -92.64M | -94.06M | -55.7M | -34.58M | -27.5M | -15.34M | -15.59M | -11.63M |